Search clinical trials for: Relapsing-Remitting,
Total 1269 results
-
Cyprus University of TechnologyThe Cyprus Foundation for Muscular Dystrophy ResearchCompletedMultiple SclerosisCyprus
-
Washington University School of MedicineCompletedRelapsing Remitting Multiple SclerosisUnited States
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Providence Health & ServicesCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jeffrey GelfandActive, not recruitingFecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis (MS-BIOME)Relapsing Remitting Multiple SclerosisUnited States
-
Amsterdam UMC, location VUmcInnovatiefonds Zorgverzekeraars; Stichting MS Research; Stichting TreatmedsEnrolling by invitationRelapsing Remitting Multiple SclerosisNetherlands
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
University of VirginiaCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Rennes University HospitalUnknown
-
Universitätsklinikum Hamburg-EppendorfCompletedRelapsing Remitting Multiple SclerosisGermany
-
University of Wisconsin, MadisonNational Multiple Sclerosis SocietyCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University of British ColumbiaGenzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisCanada
-
Johns Hopkins UniversityWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
InteKrin Therapeutics, Inc.Completed
-
BayerCompletedMultiple Sclerosis, Relapsing RemittingBelgium, Bosnia and Herzegovina, Italy, Austria, Croatia, Czechia, France, Greece, Hungary, Spain, Switzerland
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
Hoffmann-La RocheHôpital de la Timone; SGS S.A.; STRAGEN ServicesCompletedRelapsing Remitting Multiple SclerosisFrance
-
RedHill Biopharma LimitedCompletedRelapsing Remitting Multiple SclerosisIsrael
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Heinrich-Heine University, DuesseldorfNovartis PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisGermany
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisRussian Federation
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Merck KGaA, Darmstadt, GermanyCompletedRelapsing Remitting Multiple Sclerosis
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Teva Neuroscience, Inc.Completed
-
Nuron Biotech Inc.UnknownRelapsing Remitting Multiple SclerosisPoland, Spain, Belarus, Bulgaria, Serbia, Ukraine, Russian Federation, Hungary, Italy, Croatia, Georgia, Lebanon
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Wayne State UniversityCompleted
-
Kyungpook National University HospitalCompletedPseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
-
Boston Scientific CorporationTerminatedRelapsing Remitting Multiple SclerosisSpain, Germany, Belgium, Poland, France, Russian Federation
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
Instituto de Investigación Sanitaria de la Fundación...Universidad Rey Juan CarlosCompletedUrinary Incontinence | Relapsing-Remitting Multiple SclerosisSpain
-
McGill UniversityInnodem NeurosciencesRecruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisCanada
-
Hikma Pharmaceuticals LLCCompletedRelapsing Remitting Multiple SclerosisAlgeria, Egypt, Jordan
-
Regina Elena Cancer InstituteIcahn School of Medicine at Mount Sinai; University of Roma La SapienzaUnknownMultiple Sclerosis | RelapseUnited States, Italy
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Artielle ImmunoTherapeuticsUnknownMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
CelgeneCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Germany